Perioperative Dexamethasone Compared with Placebo as an Adjunct Pain Relief on Women Undergoing Caesarean Section at Federal Medical Centre, Owo: Randomized Controlled Trial

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202407850473997

Enrollment

146

Registered

2024-07-16

Start date

2024-07-05

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Dexamethasone

Normal saline

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: i. Women within the ages of 18 to 35 years ii. Women who gave written informed consent iii. No contraindication to spinal anaesthesia iv. American Society of Anesthesiologists’ physical status (ASA class I and II)

Exclusion criteria

Exclusion criteria: i. Patient’s refusal ii. History of glaucoma iii. History of chronic pain iv. History of allergy to steroid v. Chronic use of steroid vi. Need for general anaesthesia vii. Patients with Antepartum haemorrhage viii. Body mass index at booking 30kg/m2

Design outcomes

Primary

Measure	Time frame
i.Postoperative pain scores with verbal rating scale assessment. ii.Time to first analgesia request. iii.Dose of opioid (pentazocine) required in 24 hours. iv.Haemodynamic status of the patient.	—

Secondary

Measure	Time frame
i. Patients with postoperative nausea and vomiting. ii. Satisfaction of the patients to the intervention using Likert scale.	—

Countries

Nigeria

Contacts

Public ContactSaheed Adebayo

Senior registrar

sirhid1005@gmail.com+2347067959789

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026